EC approves Roche's Polivy combo in patients with previously treated aggressive lymphoma Medical Dialogues Bureau22 Jan 2020 11:01 AM ISTRoche announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in combination with...
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 9:30 AM ISTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...